Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2021 07:30 ET | Source: Avalo Therapeutics

Avalo Therapeutics to Host Virtual Investor Day on January 6, 2022

WAYNE, Pa. and ROCKVILLE, Md., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and...
December 06, 2021 07:30 ET | Source: Avalo Therapeutics

Avalo Appoints Two New Independent Directors to Its Board

WAYNE, Pa. and ROCKVILLE, Md., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and...
November 11, 2021 07:00 ET | Source: Avalo Therapeutics

Avalo to Present at Two Upcoming Conferences

WAYNE, Pa. and ROCKVILLE, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and...
November 09, 2021 16:01 ET | Source: Avalo Therapeutics

Avalo Reports Third Quarter 2021 Financial Results and Provides Business Updates

Topline Phase 1b data for AVTX-002 in moderate to severe Crohn's disease patients expected in the fourth quarter of 2021Multiple data readouts across programs anticipated within the next six...
October 13, 2021 07:00 ET | Source: Avalo Therapeutics

Avalo to Present at the Jefferies Virtual Next Generation IBD Therapeutics Summit

WAYNE, Pa. and ROCKVILLE, Md., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and...
September 20, 2021 07:00 ET | Source: Avalo Therapeutics

Avalo to Present at the 2021 Cantor Virtual Global Healthcare Conference

WAYNE, Pa. and ROCKVILLE, Md., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and...
September 17, 2021 09:11 ET | Source: Avalo Therapeutics

Avalo Therapeutics, Inc. Announces Closing of a $31.5 Million Public Offering of Common Stock, Including Proceeds from Exercise of Option to Purchase Additional Shares

WAYNE, Pa. and ROCKVILLE, Md., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (“Avalo” or the “Company”) (Nasdaq: AVTX), a leading clinical-stage precision medicine company that...
September 14, 2021 22:23 ET | Source: Avalo Therapeutics

Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock

WAYNE, Pa. and ROCKVILLE, Md., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (“Avalo” or the “Company”) (Nasdaq: AVTX), a leading clinical-stage precision medicine company that...
September 14, 2021 16:01 ET | Source: Avalo Therapeutics

Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

WAYNE, Pa. and ROCKVILLE, Md., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (“Avalo” or the “Company”) (Nasdaq: AVTX), a leading clinical-stage precision medicine company that...
August 26, 2021 07:30 ET | Source: Cerecor Inc.

Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.

Name change underscores the Company’s transition to developing innovative targeted therapies in immunology, immuno-oncology, and rare genetic diseasesRobust pipeline of six product candidates...